Without insurance, both brand-name medications are expensive typically $900 to $1,400 per month at retail price
However, the company that makes Ozempic, Novo Nordisk, does not sell semaglutide for compounding, raising concerns about where compounded semaglutide comes from and the possible use of different formulas
By promoting weight loss, Semaglutide can lead to better health outcomes and reduce the burden of chronic disease
Some healthcare providers also worry that restricting access to compounded semaglutide injections could leave patients with fewer options, particularly those who may have difficulty obtaining or affording brand-name medications, as there is currently no generic option
Future research should study further the interactions of these medications on long-term impacts on obesity